Journal Papers 856 Related Insights 0
Comparative effectiveness and safety of upadacitinib versus vedolizumab in anti-TNF-exposed patients with ulcerative colitis Jian Wan, MD; Hao Zhang, MD; Xiaojie Yuan, PhD; Zhengyu Ren, MD; Sumei Sha, MD; Changyue Wu, MD; Yingchao Li, MD, PhD; Xin Liu, MD, PhD; Xin Wang, MD, PhD; Jiaming Zhou, MD; Chuhan Hu, MD; Fei Chen, MD; Min Chen, MD, PhD; Jie Liang, MD, PhD; Kaichun Wu, MD, PhD Share Save
Effectiveness, safety, and clinical outcomes of treatment with the oral α4-integrin antagonist carotegrast methyl in patients with active ulcerative colitis: a multicenter observational study (CANAL study) Fumihito Hirai, MD, PhD; Katsuyoshi Matsuoka, MD, PhD; Kenji Watanabe, MD, PhD; Ryota Hokari, MD, PhD; Taku Kobayashi, MD, PhD; Masayuki Saruta, MD, PhD; Hiroshi Nakase, MD, PhD; Takayuki Yamamoto, MD, PhD; Mao Matsubayashi, MD, PhD; Ryuichi Okamoto, MD, PhD; Shinichiro Shinzaki, MD, PhD; Makoto Naganuma, MD, PhD; Hitoshi Hongo, MD, PhD; Hirozumi Obata, MD, PhD; Katsuya Endo, MD, PhD; Akihiro Yamada, MD, PhD; Shinya Ashizuka, MD, PhD; Noritaka Takatsu, MD, PhD; Toshiyuki Sakurai, MD, PhD; Tetsuya Ishida, MD, PhD; Jun Kato, MD, PhD; Masayuki Fukata, MD, PhD; Yusuke Takashima, MD; Yoshiyuki Hosoi, BSc; Takahiro Suzuki, MSc; Gakuto Yamazaki, BS; Toshifumi Hibi, MD, PhD; Mamoru Watanabe, MD, PhD; Tadakazu Hisamatsu, MD, PhD Share Save
Incidence, risk factors, and treatment patterns of pouchitis in pediatric ulcerative colitis Rosa S Kim, MD; Raissa Li, MD; Eamon Callison, MD, PhD; Leah Froehl, MD; Steven J Staffa, MS; David Zurakowski, MS, PhD; Caitlin Phinney, MSN; Caitlin Dolan, MS; Craig Lillehei, MD; Robert C Shamberger, MD; Paul A Rufo, MD; Athos Bousvaros, MD; Lauren V Collen, MD; Jill M Zalieckas, MD; Prathima Nandivada, MD; Lori A Zimmerman, MD Share Save
Fecal calprotectin changes after polyethylene glycol bowel preparation in patients with ulcerative colitis in remission Claudia Herrera-deGuise, MD, PhD; Encarna Varela, MD; Virginia Robles Alonso, MD, PhD; Luis Mayorga Ayala, MD; Elena Céspedes Martinez, MD; Xavier Serra Ruiz, MD; Ernesto Lastiri, MD; Elena Oller, RN; Zahira Perez, RN, MsC; Natalia Borruel Sainz, MD, PhD Share Save
Comparative effectiveness of infliximab vs vedolizumab as first-line biologic therapy in moderate-to-severe ulcerative colitis: A prospective, multicenter, real-world study Dongdong He, MM; Sumei Sha, MD; Xiaolei Liu, MD; Pengfei Yin, MD; Xiaodong Qu, MD; Xinyu Wang, MM; Na Wang, MD; Xin Feng, MM; Zixuan Zhang, MM; Wenting Zhang, MD; Yongquan Shi, MD; Min Chen, MD Share Save
Revisiting the role of lymphatics in Crohn’s disease Catherine Le Berre, MD, PhD; Ashkan Rezazadeh Ardabili, MD, PhD; Rafael Czepielewski, PhD; Ahuva Cices, MD; Saurabh Mehandru, MD, PhD; Jean-Frédéric Colombel, MD, PhD Share Save
Comparative assessment of nutritional status and energy expenditure in relation to dietary intake in hospitalized and outpatient patients with inflammatory bowel disease across disease phases Tessa C Oude Vrielink, MD; Peter B F Mensink, MD, PhD; Inge Oude Meijers, BSc; Marita Klein Jäger, BSc; Job van der Palen, MD, PhD; Henri Braat, MD, PhD; Wouter Tobias van Haaften, MD, PhD Share Save
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
